CBRE vs CPIX · P/E 43, rev $35.77B vs rev $10.4M
CBRE Group Inc Class A (CBRE) versus Cumberland Pharmaceuticals Inc (CPIX) — a side-by-side from cached financials, not a winner call.
CBRE Group Inc Class A (CBRE) is a real estate services company listed on US.
Cumberland Pharmaceuticals Inc (CPIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CBRE revenue for 2024-12-31 was $35.77B. Net income was $1.04B. Revenue was up 12.0% from 2023-12-31 to 2024-12-31. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
Latest reported CPIX revenue for 2024-12-31 was $10.4M. Net income was -$1.9M. Revenue was up 14.9% from 2024-09-30 to 2024-12-31. CPIX currently screens at market cap $86.9M.
CBRE currently screens at market cap $41.66B and trailing P/E 42.7. CPIX currently screens at market cap $86.9M.
Not investment advice. Open the CBRE and CPIX stock pages for the full models.
Not investment advice.